H. Lundbeck A/S (HLBBF)
OTCMKTS · Delayed Price · Currency is USD
5.15
-0.18 (-3.38%)
At close: Jul 25, 2025
H. Lundbeck Market Cap
H. Lundbeck has a market cap or net worth of $5.01 billion as of August 1, 2025. Its market cap has decreased by -10.18% in one year.
Market Cap
5.01B
Enterprise Value
6.94B
Revenue
3.33B
Ranking
n/a
PE Ratio
10.51
Stock Price
$5.15
Market Cap Chart
Since June 10, 2022, H. Lundbeck's market cap has increased from 4.54B to 5.01B, an increase of 10.37%. That is a compound annual growth rate of 3.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 5.01B | -8.70% |
| Dec 30, 2024 | 5.49B | 16.62% |
| Dec 29, 2023 | 4.70B | 28.73% |
| Dec 30, 2022 | 3.65B | -19.48% |
| Jun 10, 2022 | 4.54B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.80B |
| Veradigm | 794.80M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 546.09M |
| Glass House Brands | 396.28M |
| Nika Pharmaceuticals | 366.89M |
| Northwest Biotherapeutics | 361.28M |
| CytoDyn | 357.98M |